Urology Experts Announces Use of Space OAR® Hydrogel for Prostate Cancer Radiation Therapy in Southwest Florida.
October 15th 2019 -Urology Experts has added a new technology for men choosing to undergo radiation therapy for prostate cancer. The new addition, Space OAR hydrogel, is a protective spacer between the prostate and the rectum. It has been clinically proven to reduce the risk of side effects during and after radiation treatment.
Urology Experts, based in Fort Myers Florida with offices in Bonita Springs and Cape Coral, headed by Dr. Miranda-Sousa a Diplomat of the American Board of Urology (ABU) with a Fellowship in Urodynamics and Neurourology. The American Board of Urology is to assure the public that an individual has: (a) received appropriate training, and (b) has a level of urologic knowledge to practice safe and effective urology. He completed his urology training with a Fellowship at the University of South Florida in Tampa. He graduated from the prestigious Universidad Peruana Cayetano Heredia School of Medicine in Lima, Peru. After his training, he moved to Massachusetts, creating a very successful practice over the course of five years. He has strong working relationships with the Massachusetts General Hospital, Lahey Clinic, Mayo Clinic and the H. Lee Moffitt Cancer Center.
Doctor Miranda Sousa says, “This is another amazing technology we are proud to bring to our practice. Space OAR® Hydrogel, revolutionizes the way physicians can treat the onset of prostate cancer”.
In April 2015, the Food and Drug Administration (FDA) cleared SpaceOAR hydrogel. In a prospective, randomized, multi-centerclinical trial in the United States, patients treated with SpaceOAR hydrogel prior to prostate cancer radiation treatment demonstrated bowel, urinary, and sexual benefits through a median of three years of follow-up. The study found that the patients thatdid not receive SpaceOAR hydrogel experienced a clinically significant decline in bowel, urinary, and sexual quality of life eight times more often than patients that received SpaceOAR hydrogel. It is a minimally invasive outpatient procedure with local or general anesthesia. Patients can immediately resume their normal activities. The gel stays in place for approximately three months and is then naturally absorbed and cleared in the urine in about six months. (1,2)For more information, visit http://urologyexperts.com or SpaceOAR.com. 1) DA Hamstra, N Mariados, J Sylvester, et al. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. Int J Radiat Oncol Biol Phys; 2017 Apr 1; 97(5): 976-9852) DA Hamstra, et al. Sexual Quality of Life Following Prostate Intensity Modulated Radiotherapy (IMRT) with a Rectal/Prostate Spacer: Secondary Analysis of a Phase III Trial. Published online: July 19, 2017 Practical Radiation Oncology. Risks associated with the implantation of SpaceOAR hydrogel: In addition to the risks associated with any medical procedure there are potential complications that may be associated with the use of the SpaceOAR System that include, but are not limited to: pain or discomfort associated with SpaceOAR hydrogel; needle penetration or injection of SpaceOAR hydrogel into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR hydrogel intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding, constipation; and rectal urgency.